Cover Story: Contraception choices for 2004
February 1st 2004Women need thorough and accurate information about the entire array of contraceptive options--new and old--so they can find their ideal method. Adherence--not efficacy--is the problem, and the hope is that greater choice will translate into fewer unintended pregnancies.
U/S Clinics: Practical guidelines for diagnosing and treating fetal hydronephrosis
February 1st 2004Bladder shape and size are clues to the etiology and extent of hydronephrosis. Knowing whether a lesion is likely to resolve on its own or respond to in utero treatment can make the difference between a positive and a negative postnatal outcome.
Legally Speaking: Case Study: Obstructed Ureter
February 1st 2004This bimonthly series is aimed at educating physicians on the pertinent aspects of litigation. Each case study provides analysis of an actual ob/gyn lawsuit defended by the New York firm of Aaronson, Rappaport, Feinstein & Deutsch, LLP.
Epilepsy and pregnancy: minimizing the risks
January 1st 2004Does maternal epilepsy increase the risk of congenital malformations, or are the antiepileptic drugs to blame? Either way, the primary goal of therapy during pregnancy is to control a woman's seizures while minimizing fetal exposure to anticonvulsive drugs.
Cover Story: Preventing breast Ca with aromatase inhibitors
December 1st 2003With new research showing that aromatase inhibitors can dramatically cut the risk of recurring breast cancer, patients will probably have many questions about drugs like anastrozole and letrozole. Two experts review the scientific evidence on these valuable agents.